Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Santaolalla, Aida"'
Autor:
Beckmann K; Cancer Epidemiology and Population Health Research Group, University of South Australia, Adelaide, Australia. Kerri.beckmann@unisa.edu.au.; Translational Oncology and Urology Research, Kings College London, London, UK. Kerri.beckmann@unisa.edu.au., Santaolalla A; Translational Oncology and Urology Research, Kings College London, London, UK., Sugimoto M; Faculty of Medicine, Kagawa University, Kagawa, Japan., Carroll P; Department of Urology, UCSF-Helen Diller Comprehensive Cancer Centre, University of California San Francisco, San Francisco, CA, USA., Rubio J; Instituto Valenciano de Oncologia, Valencia, Spain., Villers A; Lille University Hospital Center, Lille, France., Bjartell A; Department of Urology, Skane University Hospital, Malmo, Sweden., Morgan T; University of Michigan and Michigan Urological Surgery Improvement Collaborative, Michigan, MI, USA., Dasgupta P; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Immunology and Microbial Sciences, King's College London, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, Kings College London, London, UK., Elhage O; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Immunology and Microbial Sciences, King's College London, London, UK.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Jun; Vol. 26 (2), pp. 403-409. Date of Electronic Publication: 2022 Aug 25.
Autor:
Beckmann KR; Cancer Epidemiology and Population Health Research, University of South Australia, Adelaide, South Australia, Australia.; Translational Oncology and Urology Research, Kings College London, London, UK., Bangma CH; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Helleman J; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bjartell A; Department of Translational Medicine, Skane University Hospital, Malmo, Sweden., Carroll PR; Department of Urology, University of California San Francisco, San Francisco, California, USA., Morgan T; Michigan Urological Surgery Improvement Collaborative, University of Michigan, Ann Arbor, Michigan, USA., Nieboer D; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Santaolalla A; Translational Oncology and Urology Research, Kings College London, London, UK., Trock BJ; The James Buchanan Brady Urological Institute, John Hopkins University, Baltimore, Maryland, USA., Valdagni R; Radiation Oncology and Prostate Cancer Program, Istituto Nazionale Dei Tumori, Milano, Italy., Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
The Prostate [Prostate] 2022 May; Vol. 82 (7), pp. 876-879. Date of Electronic Publication: 2022 Mar 07.
Autor:
Marsden T; Division of Surgical and Interventional Sciences, University College London, London, UK teresa.marsden@ucl.ac.uk.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Lomas DJ; Department of Urology, Mayo Clinic, Rochester, New York, USA., McCartan N; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Hadley J; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Tuck S; ReIMAGINE Consortium Patient Representative, University College London, London, UK., Brown L; MRC Clinical Trials Unit, University College London, London, UK., Haire A; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Moss CL; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Green S; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Coolen T; London Institute for Mathematical Sciences, London, UK., Santaolalla A; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK., Isaac E; Centre for Medical Imaging, University College London, London, UK., Brembilla G; Centre for Medical Imaging, University College London, London, UK., Kopcke D; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Giganti F; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Sidhu H; Centre for Medical Imaging, University College London, London, UK., Punwani S; Centre for Medical Imaging, University College London, London, UK., Emberton M; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Moore CM; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Sep 30; Vol. 11 (9), pp. e048144. Date of Electronic Publication: 2021 Sep 30.
Autor:
Singh S; School of Medical Education, Faculty of Life Sciences and Medicine, King's College London, London, UK.; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Sandhu P; School of Medical Education, Faculty of Life Sciences and Medicine, King's College London, London, UK.; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Beckmann K; Translational Oncology and Urology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK.; University of South Australia Cancer Research Institute, University of South Australia, Adelaide, SA, Australia., Santaolalla A; Translational Oncology and Urology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK., Dewan K; School of Medical Education, Faculty of Life Sciences and Medicine, King's College London, London, UK., Clovis S; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Rusere J; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Zisengwe G; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Challacombe B; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Brown C; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Cathcart P; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Popert R; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Dasgupta P; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, Kings College London, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK., Elhage O; The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, Kings College London, London, UK.
Publikováno v:
BJU international [BJU Int] 2021 Jul; Vol. 128 (1), pp. 72-78. Date of Electronic Publication: 2020 Nov 15.
Autor:
Kum F; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK., Beckmann K; Cancer Research Institute, University of South Australia, Adelaide, SA, Australia. kerri.beckmann@unisa.edu.au.; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. kerri.beckmann@unisa.edu.au., Aya H; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK., Singh S; Faculty of Life Sciences & Medicine, King's College London, London, UK., Sandhu P; Faculty of Life Sciences & Medicine, King's College London, London, UK., Sra S; Faculty of Life Sciences & Medicine, King's College London, London, UK., Rusere J; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Zisengwe G; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Santaolalla A; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Cathcart P; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Challacombe B; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK., Brown C; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Popert R; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Dasgupta P; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, Kings College London, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Elhage O; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, Kings College London, London, UK.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Jun; Vol. 24 (2), pp. 549-557. Date of Electronic Publication: 2021 Feb 08.
Autor:
Shah S; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK., Beckmann K; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK.; Cancer Research Institute, University of South Australia, Adelaide, Australia., Van Hemelrijck M; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK., Challacombe B; King's College London, London, UK & Guy's and St Thomas' NHS Foundation Trust, London, UK., Popert R; King's College London, London, UK & Guy's and St Thomas' NHS Foundation Trust, London, UK., Dasgupta P; King's College London, London, UK & Guy's and St Thomas' NHS Foundation Trust, London, UK., Rusere J; King's College London, London, UK & Guy's and St Thomas' NHS Foundation Trust, London, UK., Zisengwe G; King's College London, London, UK & Guy's and St Thomas' NHS Foundation Trust, London, UK., Elhage O; King's College London, London, UK & Guy's and St Thomas' NHS Foundation Trust, London, UK., Santaolalla A; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK. aida.santaolalla@kcl.ac.uk.
Publikováno v:
BMC cancer [BMC Cancer] 2021 May 19; Vol. 21 (1), pp. 573. Date of Electronic Publication: 2021 May 19.
Autor:
Marsden T; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: teresa.marsden@ucl.ac.uk., McCartan N; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Hadley J; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Tuck S; ReIMAGINE Consortium Patient Representative., Brown L; MRC Clinical Trials Unit, University College London, London, UK., Haire AJ; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Moss CL; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Green S; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Coolen T; London Institute for Mathematical Sciences, London, UK., Santaolalla A; Cancer Epidemiology Group, Division of Cancer Studies, King's College London School of Medicine, London, UK., Isaac E; Centre for Medical Imaging, University College London, London, UK., Brembilla G; Centre for Medical Imaging, University College London, London, UK., Kopcke D; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Giganti F; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Sidhu H; Centre for Medical Imaging, University College London, London, UK., Punwani S; Centre for Medical Imaging, University College London, London, UK., Emberton M; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Moore CM; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
European urology focus [Eur Urol Focus] 2021 May; Vol. 7 (3), pp. 503-505. Date of Electronic Publication: 2021 Apr 23.
Autor:
Essén A; Research Oncology, Translational Oncology & Urology Research (TOUR), Guy's Hospital, School of Cancer and Pharmaceutical Sciences, King's College London, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK., Santaolalla A; Research Oncology, Translational Oncology & Urology Research (TOUR), Guy's Hospital, School of Cancer and Pharmaceutical Sciences, King's College London, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK., Garmo H; Research Oncology, Translational Oncology & Urology Research (TOUR), Guy's Hospital, School of Cancer and Pharmaceutical Sciences, King's College London, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK.; Regional Cancer Centre, Uppsala, Sweden., Hammar N; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Medical Evidence & Observational Research, Global Medical Affairs, AstraZeneca, Mölndal, Sweden., Walldius G; Department of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Jungner I; Department of Clinical Epidemiology, Karolinska Institutet and CALAB Research, Stockholm, Sweden., Malmström H; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Biostatistics, Research & Development, Swedish Orphan Biovitrum AB, Stockholm, Sweden., Holmberg L; Research Oncology, Translational Oncology & Urology Research (TOUR), Guy's Hospital, School of Cancer and Pharmaceutical Sciences, King's College London, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Van Hemelrijck M; Research Oncology, Translational Oncology & Urology Research (TOUR), Guy's Hospital, School of Cancer and Pharmaceutical Sciences, King's College London, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK. mieke.vanhemelrijck@kcl.ac.uk.; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. mieke.vanhemelrijck@kcl.ac.uk.
Publikováno v:
Cancer causes & control : CCC [Cancer Causes Control] 2019 Jun; Vol. 30 (6), pp. 603-615. Date of Electronic Publication: 2019 Apr 24.
Autor:
van der Kwast TH; Department of Pathology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. Electronic address: theodorus.vanderkwast@uhn.ca., Helleman J; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Nieboer D; Department of Urology, Erasmus MC, Rotterdam, The Netherlands; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands., Bruinsma SM; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Roobol MJ; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Trock B; Johns Hopkins University, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Ehdaie B; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carroll P; University of California San Francisco, San Francisco, CA, USA., Filson C; Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA., Kim J; MD Anderson Cancer Centre, Houston, TX, USA., Logothetis C; MD Anderson Cancer Centre, Houston, TX, USA., Morgan T; University of Michigan and Michigan Urological Surgery Improvement Collaborative, Michigan, USA., Klotz L; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Pickles T; University of British Columbia, BC Cancer Agency, Vancouver, Canada., Hyndman E; University of Calgary, Southern Alberta Institute of Urology, Calgary, Canada., Moore CM; University College London and University College London Hospital Trust, London, UK., Gnanapragasam V; University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Van Hemelrijck M; King's College London, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK., Dasgupta P; Guy's and St Thomas' NHS Foundation Trust, London, UK., Bangma C; Erasmus Medical Center, Rotterdam, The Netherlands., Roobol M; Erasmus Medical Center, Rotterdam, The Netherlands., Villers A; Lille University Hospital Center, Lille, France., Rannikko A; Helsinki University and Helsinki University Hospital, Helsinki, Finland., Valdagni R; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1 and Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Perry A; University College Dublin, Dublin, Ireland., Hugosson J; Sahlgrenska University Hospital, Göteborg, Sweden., Rubio-Briones J; Instituto Valenciano de Oncología, Valencia, Spain., Bjartell A; Skåne University Hospital, Malmö, Sweden., Hefermehl L; Kan-tonsspital Baden, Baden, Switzerland., Shiong LL; Singapore General Hospital, Singapore, Singapore., Frydenberg M; Monash Health; Monash University, Melbourne, Australia., Kakehi Y; Kagawa University Faculty of Medicine, Kagawa, Japan., Chung BH; Gangnam Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea., van der Kwast T; Princess Margaret Cancer Centre, Toronto, Canada., Obbink H; Royal Philips, Eindhoven, The Netherlands., van der Linden W; Royal Philips, Eindhoven, The Netherlands., Hulsen T; Royal Philips, Eindhoven, The Netherlands., de Jonge C; Royal Philips, Eindhoven, The Netherlands., Kattan M; Cleveland Clinic, Cleveland, OH, USA., Xinge J; Cleveland Clinic, Cleveland, OH, USA., Muir K; University of Manchester, Manchester, UK., Lophatananon A; University of Manchester, Manchester, UK., Fahey M; Epworth HealthCare, Melbourne, Australia., Steyerberg E; Erasmus Medical Center, Rotterdam, The Netherlands., Nieboer D; Erasmus Medical Center, Rotterdam, The Netherlands., Zhang L; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Guo W; Johns Hopkins University, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Benfante N; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cowan J; University of California San Francisco, San Francisco, CA, USA., Patil D; Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA., Tolosa E; MD Anderson Cancer Centre, Houston, TX, USA., Kim TK; University of Michigan and Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI, USA., Mamedov A; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., LaPointe V; University of British Columbia, BC Cancer Agency, Vancouver, Canada., Crump T; University of Calgary, Southern Alberta Institute of Urology, Calgary, Canada., Kimberly-Duffell J; University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Santaolalla A; King's College London, London, UK., Nieboer D; Erasmus Medical Center, Rotterdam, The Netherlands., Olivier JT; Lille University Hospital Center, Lille, France., Rancati T; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Ahlgren H; Sahlgrenska University Hospital, Göteborg, Sweden., Mascarós J; Instituto Valenciano de Oncología, Valencia, Spain., Löfgren A; Skåne University Hospital, Malmö, Sweden., Lehmann K; Kantonsspital Baden, Baden, Switzerland., Lin CH; Monash University and Epworth HealthCare, Melbourne, Australia., Hirama H; Kagawa University, Kagawa, Japan., Lee KS; Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea., Jenster G; Erasmus MC, Rotterdam, The Netherlands., Auvinen A; University of Tampere, Tampere, Finland., Bjartell A; Instituto Valenciano de Oncología, Valencia, Spain., Haider M; University of Toronto, Toronto, Canada., van Bochove K; The Hyve B.V. Utrecht, Utrecht, The Netherlands., Carter B; Johns Hopkins University, Baltimore, MD, USA., Gledhill S; Movember Foundation, Melbourne, Australia., Buzza M; Movember Foundation, Melbourne, Australia., Bangma C; Erasmus Medical Center, Rotterdam, The Netherlands., Roobol M; Erasmus Medical Center, Rotterdam, The Netherlands., Bruinsma S; Erasmus Medical Center, Rotterdam, The Netherlands., Helleman J; Erasmus Medical Center, Rotterdam, The Netherlands.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2019 May; Vol. 2 (3), pp. 333-336. Date of Electronic Publication: 2018 Sep 13.
Autor:
Beckmann, Kerri, Santaolalla, Aida, Sugimoto, Mikio, Carroll, Peter, Rubio, Jose, Villers, Arnauld, Bjartell, Anders, Morgan, Todd, Dasgupta, Prokar, Van Hemelrijck, Mieke, Elhage, Oussama, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
Publikováno v:
Prostate cancer and prostatic diseases, vol 26, iss 2
BackgroundCurrently, follow-up protocols are applied equally to men on active surveillance (AS) for prostate cancer (PCa) regardless of findings at their initial follow-up biopsy. To determine whether less intensive follow-up is suitable following ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::9c99680c86f1ed8249c4298ddae8a8e3
https://escholarship.org/uc/item/5dk12186
https://escholarship.org/uc/item/5dk12186